Biopharma Co. Advicenne Plans Cross-Listing In Brussels
French pharmaceutical company Advicenne said it plans to list on the Euronext Brussels in a proposed secondary listing that would see the Paris-listed company's shares trade on the two largest Euronext...To view the full article, register now.
Already a subscriber? Click here to view full article